SAMIL PHARMACEUTICAL CO.,LTD
Develops & manufactures drugs for eye & liver diseases, with a broad portfolio & CDMO services.
000520 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 효령로 155 (방배동, 삼일제약 사옥), 서초구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Samil Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and sale of a wide range of medicines and quasi-drugs. The company specializes in ophthalmology and maintains a research and development pipeline focused on treatments for eye and liver diseases. Its broader product portfolio includes medications for hepatic, gastrointestinal, respiratory, circulatory, and central nervous system (CNS) conditions. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services and collaborates with global partners to bring innovative therapies to market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.5 MB | ||
| 2025-05-15 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 43.5 KB | ||
| 2025-05-15 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.7 KB | ||
| 2025-04-16 00:00 |
Share Issue/Capital Change
유상증자또는주식관련사채등의발행결과(자율공시)
|
Korean | 5.6 KB | ||
| 2025-04-16 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 21.3 KB | ||
| 2025-04-11 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 20.8 KB | ||
| 2025-04-11 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 32.5 KB | ||
| 2025-04-11 00:00 |
Capital/Financing Update
기타경영사항(자율공시)
|
Korean | 6.4 KB | ||
| 2025-04-11 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 31.8 KB | ||
| 2025-04-10 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-04-08 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 41.8 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 41.8 KB | ||
| 2025-03-28 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.2 MB | ||
| 2025-03-21 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 29.4 KB |
Automate Your Workflow. Get a real-time feed of all SAMIL PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SAMIL PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
